Equity Investing
Is Anything Boosting Actinium (ATNM) Stock In Pre-Market Trading?
Following the release of favorable clinical-trial findings, Actinium Pharmaceuticals Inc. (NYSE: ATNM) shares increased 8.22% to trade at $10.53 at the time of the most